SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-24-022270
Filing Date
2024-05-31
Accepted
2024-05-31 21:30:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 164554
  Complete submission text file 0001493152-24-022270.txt   166253
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 212-710-5220
VEDANTA PARTNERS, LLC (Filed by) CIK: 0001502216 (see all company filings)

IRS No.: 261741447 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90624 | Film No.: 241011781
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)